Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age

Caroline Breese Hall1, Geoffrey A Weinberg, Aaron K Blumkin

  • 1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.

Pediatrics
|July 24, 2013
PubMed

Insights

Young infants, particularly one-month-olds, face the highest risk of respiratory syncytial virus (RSV) hospitalization. Most hospitalized infants were previously healthy, highlighting the need for broad preventive strategies against RSV.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Respiratory syncytial virus (RSV) is a primary cause of infant hospitalizations.
  • Previous RSV hospitalization burden estimates lacked precision due to broad age groupings.

Purpose of the Study:

  • To precisely estimate the hospitalization burden of RSV in young children.
  • To identify age-specific risks for RSV hospitalization.

Main Methods:

  • Prospective, population-based surveillance of laboratory-confirmed RSV acute respiratory illness (ARI) hospitalizations over five years (2000-2005).
  • Stratification of the population by month of age to calculate precise hospitalization rates.

Main Results:

  • The average RSV hospitalization rate was 5.2 per 1000 children under 24 months.
  • Infants 1 month old had the highest age-specific rate (25.9 per 1000).
  • Infants ≤ 2 months accounted for 44% of RSV hospitalizations, with a rate of 17.9 per 1000.

Conclusions:

  • One-month-old infants are at the greatest risk for RSV hospitalization.
  • The majority (79%) of RSV-hospitalized infants were previously healthy.
  • Universal preventive strategies are essential for all young infants to reduce RSV hospitalizations.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...